• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[1, 2, 4] - 恶二唑:合成及其生物学应用

[1, 2, 4]-oxadiazoles: synthesis and biological applications.

作者信息

Bora Rajesh O, Dar Bashir, Pradhan Vidya, Farooqui Mazahar

机构信息

Post Graduate and Research centre, Maulana Azad College, Aurangabad, and Indian Institute of Integrative Medicine Jammu 180001.

出版信息

Mini Rev Med Chem. 2014 Apr;14(4):355-69. doi: 10.2174/1389557514666140329200745.

DOI:10.2174/1389557514666140329200745
PMID:24678879
Abstract

In the present article synthesis and medicinal applications of [1, 2, 4] oxadiazoles are reviewed. The oxadiazoles have a wide range of applications such as Antitussive, Anti-inflammatory, Anaesthetic, Vasodilator, anthelmintic, antiallergic, antiplatelet effects in vitro, antithrombotic properties in vivo, etc. Many researchers have synthesized novel heterocyclic compounds containing oxadiazoles with the concept of bioisosterism.

摘要

在本文中,对[1, 2, 4]恶二唑的合成及其医学应用进行了综述。恶二唑具有广泛的应用,如镇咳、抗炎、麻醉、血管舒张、驱虫、抗过敏、体外抗血小板作用、体内抗血栓形成特性等。许多研究人员基于生物电子等排体的概念合成了含恶二唑的新型杂环化合物。

相似文献

1
[1, 2, 4]-oxadiazoles: synthesis and biological applications.[1, 2, 4] - 恶二唑:合成及其生物学应用
Mini Rev Med Chem. 2014 Apr;14(4):355-69. doi: 10.2174/1389557514666140329200745.
2
Searching for new NO-donor aspirin-like molecules: Furoxanylacyl derivatives of salicylic acid and related furazans.寻找新型 NO 供体阿司匹林类似物:水杨酸和相关呋咱的呋喃甲酰基衍生物。
Bioorg Med Chem. 2011 Oct 1;19(19):5852-60. doi: 10.1016/j.bmc.2011.08.018. Epub 2011 Aug 16.
3
[Synthesis and antithrombotic activity of acetylsalicyl ferulic acid-coupling furoxans and nitrates].乙酰水杨酸阿魏酸偶联呋咱和硝酸盐的合成及其抗血栓活性
Yao Xue Xue Bao. 2006 Nov;41(11):1050-6.
4
Pharmacochemistry of the furoxan ring: recent developments.呋咱环的药物化学:最新进展
Farmaco. 1993 Feb;48(2):321-34.
5
Design, synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing methyl ferulate.新型含甲基阿魏酸达比加群酯前药的设计、合成与抗血栓评价。
Bioorg Med Chem Lett. 2013 Apr 1;23(7):2089-92. doi: 10.1016/j.bmcl.2013.01.126. Epub 2013 Feb 8.
6
Design, synthesis and evaluation of nitric oxide releasing derivatives of 3-n-butylphthalide as antiplatelet and antithrombotic agents.设计、合成及评价 3-正丁基苯酞一氧化氮供体型衍生物作为抗血小板和抗血栓药物。
Org Biomol Chem. 2011 Aug 21;9(16):5670-81. doi: 10.1039/c1ob05478c. Epub 2011 Jun 24.
7
Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative.新合成的1,4-萘醌衍生物2-氯-3-[4-(乙基羧基)-苯基]-氨基-1,4-萘醌(NQ12)的抗血栓形成和抗血小板活性
Biochem Pharmacol. 2000 Oct 1;60(7):1001-8. doi: 10.1016/s0006-2952(00)00411-1.
8
1,3,4-oxadiazole: a biologically active scaffold.1,3,4-噁二唑:一种具有生物活性的支架。
Mini Rev Med Chem. 2012 Jul;12(8):789-801. doi: 10.2174/138955712801264800.
9
New NO-donors with antithrombotic and vasodilating activities, VIII: Benzothiazole-2(3H)-nitrosimines.具有抗血栓形成和血管舒张活性的新型一氧化氮供体,VIII:苯并噻唑-2(3H)-亚硝基胺
Arch Pharm (Weinheim). 1994 Dec;327(12):771-7. doi: 10.1002/ardp.19943271204.
10
1,2,4-Oxadiazole as a Privileged Scaffold for Anti-inflammatory and Analgesic Activities: A Review.1,2,4-恶二唑作为抗炎和镇痛活性的优势骨架:综述。
Mini Rev Med Chem. 2018;18(18):1536-1547. doi: 10.2174/1389557518666180524112050.

引用本文的文献

1
Exploring Probenecid Derived 1,3,4-Oxadiazole-Phthalimide Hybrid as α-Amylase Inhibitor: Synthesis, Structural Investigation, and Molecular Modeling.探索丙磺舒衍生的1,3,4-恶二唑-邻苯二甲酰亚胺杂化物作为α-淀粉酶抑制剂:合成、结构研究及分子模拟
Pharmaceuticals (Basel). 2023 Mar 10;16(3):424. doi: 10.3390/ph16030424.
2
Simple and Efficient Synthesis of Diamino Derivatives of bis-1,2,4-oxadiazole Tandem Staudinger/aza-Wittig Reaction.双-1,2,4-噁二唑的二氨基衍生物的简单高效合成 通过Staudinger/aza-Wittig 串联反应。
Curr Org Synth. 2023;20(6):589-594. doi: 10.2174/1570179420666221006113032.
3
A review on synthetic account of 1,2,4-oxadiazoles as anti-infective agents.
综述:作为抗感染药物的 1,2,4-噁二唑的合成研究。
Mol Divers. 2022 Oct;26(5):2967-2980. doi: 10.1007/s11030-021-10375-4. Epub 2022 Jan 5.
4
Synthesis of 5-arylacetylenyl-1,2,4-oxadiazoles and their transformations under superelectrophilic activation conditions.5-芳基乙炔基-1,2,4-恶二唑的合成及其在超亲电活化条件下的转化
Beilstein J Org Chem. 2021 Sep 15;17:2417-2424. doi: 10.3762/bjoc.17.158. eCollection 2021.
5
Design, Synthesis and Antiparasitic Evaluation of Click Phospholipids.点击型磷脂的设计、合成与抗寄生虫评估
Molecules. 2021 Jul 10;26(14):4204. doi: 10.3390/molecules26144204.
6
Novel chalcone/aryl carboximidamide hybrids as potent anti-inflammatory via inhibition of prostaglandin E2 and inducible NO synthase activities: design, synthesis, molecular docking studies and ADMET prediction.新型查尔酮/芳基甲脒类杂合物通过抑制前列腺素 E2 和诱导型一氧化氮合酶活性发挥强效抗炎作用:设计、合成、分子对接研究和 ADMET 预测。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1067-1078. doi: 10.1080/14756366.2021.1929201.
7
Novel 3'-Substituted-1',2',4'-Oxadiazole Derivatives of 18βH-Glycyrrhetinic Acid and Their -Acylated Amidoximes: Synthesis and Evaluation of Antitumor and Anti-Inflammatory Potential In Vitro and In Vivo.新型 18βH-甘草次酸 3'-取代-1',2',4'-恶二唑衍生物及其酰化酰胺肟:体外和体内抗肿瘤和抗炎活性的评价。
Int J Mol Sci. 2020 May 15;21(10):3511. doi: 10.3390/ijms21103511.
8
Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-Targets.合成、计算机模拟和基于体外实验评价含恶二唑和吲哚嗪结构化合物的抗利什曼原虫活性:针对抗靶标化合物。
Molecules. 2019 Apr 2;24(7):1282. doi: 10.3390/molecules24071282.
9
Multistep Synthesis of 1,2,4-Oxadiazoles via DNA-Conjugated Aryl Nitrile Substrates.通过与 DNA 连接的芳基腈底物的多步合成 1,2,4-恶二唑
Bioconjug Chem. 2019 May 15;30(5):1304-1308. doi: 10.1021/acs.bioconjchem.9b00188. Epub 2019 Apr 10.
10
Metal-free hydroarylation of the side chain carbon-carbon double bond of 5-(2-arylethenyl)-3-aryl-1,2,4-oxadiazoles in triflic acid.在三氟甲磺酸中5-(2-芳基乙烯基)-3-芳基-1,2,4-恶二唑侧链碳-碳双键的无金属氢芳基化反应
Beilstein J Org Chem. 2017 May 11;13:883-894. doi: 10.3762/bjoc.13.89. eCollection 2017.